Follicle-stimulating hormone receptors: a new immunohistochemical marker in cancers?
|
| Abstract | PURPOSE:
Follicle-stimulating hormone receptors (FSHR) have been reported in ovarian cancer and prostate cancer cells, but recent studies have highlighted their presence in the endothelium of blood vessels belonging to multiple neoplasias. Current research attempts to determine the role of FSHR in neoplastic proliferation and possible therapeutic or diagnostic implications. This paper aimed to analyze articles that have revealed the presence and/or role of FSHR in various neoplasms in humans. METHODS: After performing an extensive search of MEDLINE/ PubMed using MeSH terms "follicle-stimulating hormone receptors" and "cancer", 22 original articles were found relevant for the subject proposed for analysis. RESULTS: FSHR were found in all neoplasms studied, being present in both tumor cells and endothelial cells of intraand perineoplasic blood vessels. Although, the presence of these receptors seemed to be ubiquitary, conclusion and the exact role of these receptors could not be stated due to heterogeneous nature of the existing studies. CONCLUSIONS: Although extensive research studies are needed in order to elucidate the exact role of FSHRs and their utility in clinical practice, joint efforts in studying their implication in neoplastic processes can lead to the use of new diagnostic and therapeutic strategies for cancer patients.
|
|---|---|
| Authors | Eduard-Alexandru Bonci, Alexandru Irimie, Rares Buiga, Ioan Cosmin Lisencu, Laura Iuliana Maja, Doina Piciu |
| Journal | Journal of B.U.ON. : official journal of the Balkan Union of Oncology (J BUON) 2017 Sep-Oct Vol. 22 Issue 5 Pg. 1352-1359 ISSN: 1107-0625 [Print] Cyprus |
| PMID | 29135125 (Publication Type: Journal Article) |
| Chemical References |
|
| Topics |
|
Join CureHunter, for free Research Interface BASIC access!
Realize the full power of the drug-disease research graph!